Spectrum of Paraneoplastic Disease Associated With Lymphoma
Neurol 76:705-710, Briani,C.,et al, 2011
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Neurologic Manifestations of SLE 1972
Nebraska State Journ Med, Oct 1972, pp 395., Aita,J., 1972
Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
Ann Neurol 91:756-771, Frontera, J.A.,et al, 2022
Neurologic Complications of Coronavirus Infections
Neurol 94:809-810, Nath, A., 2020
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
GQ1b-Seronegative Miller Fisher Syndrome Associated with Pembrolizumab
J Neuro-Ophthal 39:394-396, Green, K.E.,et al, 2019
Acute Onset of Diplopia in Pregnancy
Neurol 91:e180-e184, Munro, Z. & Fernandez, D., 2018
Neuroimaging Findings of Zika Virus-Associated Neurologic Complications in Adults
AJNR 39:1967-1974, Hygino da Cruz, L.C.,et al, 2018
Acute Bulbar Palsy as a Variant of Guillain-Barre Syndrome
Neurol 86:742-747, Kim, J.K.,et al, 2016
Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Mycoplasma Pneumoniae
Adams & Victors Principles of Neurology, Chp 32, pg 708, Ropper, A.H.,et al, 2014
Association between Guillain-Barr� Syndrome and Influenza a (H1N1) 2009 Monovalent Inactivated Vaccines in the USA: A Meta-Analysis
Lancet 381:1461-1468, Salmon, D.,et al, 2013
Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
Should I Have an H1N1 Flu Vaccination After Guillain-Barr�
BMJ 339:635, Price,L., 2009
Continuous Spectrum of Pharyngeal-Cervical-Brachial Variant of Guillain-Barr� Syndrome
Arch Neurol 64:1519-1523, Nagashima,T.,et al, 2007
Isolated Abducens Nerve Palsy as a Regional Variant of Guillain-Barre Syndrome
JNS 243:35-38, Tatsumoto, M.,et al, 2006
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Neurologic Adverse Events Associated With Smallpox Vaccination in the United States, 2002-2004
JAMA 294:2744-2750, Sejvar,J.J.,et al, 2005
Adverse Events Reported Following Live, Cold-Adapted, Intranasal Influenza Vaccine
JAMA 294:2720-2725, Izurieta,H.S.,et al, 2005
Acute Facial Diplegia and Hyperreflexia
Neurol 62:825-827, Susuki,K.,et al, 2004
Guillain-Barre Syndrome Follwoing Influenza Vaccination
JAMA 292:2478-2481, Haber,P.,et al, 2004
Bickerstaff's Brainstem Encephalitis: Clinical Features of 62 Cases and a Subgroup Associated with Guillain-Barre Syndrome
Brain 126:2279-2290, Odaka,M.,et al, 2003
Neurological Involvement in Acute Q Fever
Arch Int Med 162:693-700, Bernit,E.,et al, 2002
Influenza Vaccine and the Risk of Relapse of Guillain-Barre Syndrome
Neurol 55:452-453, Wijdicks,E.F.M. et al, 2000
Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999
Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998
The Guillain-Barre Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines
NEJM 339:1797-1802,1845, Lasky,T.,et al, 1998
Measles Vaccination and Guillain-Barre Syndrome
349:14-16, daSilveira,C.M.,et al, 1997
Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
An Acute Neurologic Syndrome Temporally Associated with Postexposure Trtm of Rabies
Pediatrics 100:720-721, Mortiere,M.D.&Falcone,A.L., 1997
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Acute Paresis of Extraocular Muscles Associated with IgG Anti-GQ Antibody
Ann Neurol 39:668-672, Yuki,N., 1996
The Clinical Correlates of High-Titer IgG Anti-GM1 Antibodies
Ann Neurol 35:234-237, Kornberg,A.J.,et al, 1994
Epidemiology of Guillain-Barre Syndrome in Children:Relationship of Oral Polio Vaccine Administration to Occurrence
J Pediatr 124:220-223, Rantala,H.,et al, 1994
Serum Antibodies to GM1, GD1b, Peripheral Nerve Myelin, & C. Jejuni in Pts with Guillain-Barre Synd & Controls
Ann Neurol 34:130-135, Vriesendorp,F.J.,et al, 1993
Guillain-Barre Syndrome (GBS) with Bilateral Optic Neuritis and Central White Matter Disease
Neurol 43:842-843, Nadkarni,M.&Lisak,R.P., 1993
Serum anti-GQ1b IgG antibody is Associated with Ophthalmoplegia in Miller Fisher Syndrome and Guillain-Barre Syndrome: Clinical and Immunohistochemical Studies
Neurol 43:1911-1917, Chiba, A.,et al, 1993
Nervous System Lyme Borreliosis-Revisited
Arch Neurol 49:102-107, Finkel,M.J.&Halperin,J.J., 1992
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
Recurrent Guillan-Barre Syndrome After Multiple Exposures to Cytomegalovirus
Am J Med 87:339-341, Donaghy,M.,et al, 1989
Acute Inflamm Demyel Polyradiculoneuro (Guillain-Barre Syndrome) After Imm with H flu Type b Conjugate Vaccine
J Pediatr 115:743-746, D'Cruz,O.F.,et al, 1989
Incidence of Guillain-Barre Syndrome During a Nationwide Oral Poliovirus Vaccine Campaign
Neurol 39:1034-1036, Kinnumen,E.,et al, 1989
Postmarketing Surveillance for Neurologic Adverse Events after Hepatitis B Vaccination, Exp of the First 3 Yrs
Am J Epidemiol 127:337-352, Shaw,F.E.,et al, 1988
Immunologic Aspects of Neurological & Neuromuscular Diseases
JAMA 258:2970-2973, Zweiman,B.&Arnason,B.G.W., 1987
Encephalomyeloneuritis Simulating Guillain-Barre Syndrome
Neurol 35:1146-1151, Brashear,H.R.,et al, 1985
Polyradiculoneuritis Secondary to Immunization with Tetanus & Diphtheria Toxoids
Arch Neurol 40:56-57, Holliday,P.L.,et al, 1983
Transverse Myelitis Caused by Duck Embryo Rabies Vaccine
Arch Neurol 39:426-430, Label,L.S.,et al, 1982